ReviewFrontiers in immunology2018

Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.

Guanxi Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.